[1] Feldman SR,Clark AR,Venkat AP,et al.The self-administered psoriasis area and severity index provides an objective measure of psoriasis severity.Br J Dermatol,2005,152:382-383.
[2] Feldman SR,Krueger GG.Psoriasis assessment tools in clinical trials.Ann Rheum Dis,2005,64 Suppl 2:ii65-73.
[3] Krueger G,Ellis CN.Psoriasis——recent advances in understanding its pathogenesis and treatment.J Am Acad Dermatol,2005,53 (1Suppl 1):S94-100.
[4] Finlay AY.Current severe psoriasis and the rule of tens.Br J Der matol,2005,152:861-867.
[5] Schon MP,Boehncke WH.Psoriasis.N Engl J Med,2005,352:1899-1912.
[6] Krueger G,Ellis CN.Psoriasis——recent advances in understanding its pathogenesis and treatment.J Am Acad Dermatol,2005,53 (1 Suppl 1):S94-100.
[7] Bos JD,de Rie MA,Teunissen MB,et al.Psoriasis:dysregulation of innate immnnity.Br J Dermatol,2005,152:1098-1107.
[8] Lebwohl M.A clinician′ s paradigm in the treatment of psoriasis.J Am Acad Dermatol,2005,53 (1 Suppl 1):S59-69.
[9] Gottlieb AB.Therapeutic options in the treatment of psoriasis and atopic dermatitis.J Am Acad Dermatol,2005,53 (1 Suppl 1):S3-16.
[10] Stein L.Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis.J Am Acad Dermatol,2005,53 (1 Suppl 1):S39-49.
[11] Del Rosso J,Friedlander SF.Corticosteroids:options in the era of steroid-sparing therapy.J Am Acad Dermatol,2005,53 (1 Suppl 1):S50-58.
[12] Robertshaw H,Friedmann PS.Pioglitazone:a promising therapy for psoriasis.Br J Dermatol,2005,152:189-191.
[13] Bongartz T,Coras B,Vogt T,et al.Treatment of active psoriatic arthritis with the PPAR gamma ligand pioglitazone:an open-label pilot study.Rheumatology (Oxford),2005,44:126-129.
[14] Smith CH,Anstey AV,Barker JN,et al.British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005.Br J Dermatol,2005,153:486-497.
[15] Koo J,Khera P.Update on the mechanisms and efficacy of biological therapies for psoriasis.J Dermatol Sci,2005,38:75-87.
[16] Mease PJ.Psoriatic arthritis therapy advances.Curr Opin Rheuma tol,2005,17:426-432.
[17] Gottlieb AB.Psoriasis:emerging therapeutic strategies.Nat Rev Drug Discov,2005,4:19-34. |
